Trial Outcomes & Findings for Minimally Invasive or Conventional Edge-To-Edge Repair for Severe Mitral Regurgitation Due to Bileaflet Prolapse in Barlow's Disease: Does the Surgical Approach Have an Impact on the Long-term Results? (NCT NCT04002648)

NCT ID: NCT04002648

Last Updated: 2020-08-07

Results Overview

The cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk

Recruitment status

COMPLETED

Target enrollment

208 participants

Primary outcome timeframe

12 years

Results posted on

2020-08-07

Participant Flow

Participant milestones

Participant milestones
Measure
MT-Right
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
Sternotomy
Sternotomy: Longitudinal resection of the sternum
Overall Study
STARTED
104
104
Overall Study
COMPLETED
102
104
Overall Study
NOT COMPLETED
2
0

Reasons for withdrawal

Reasons for withdrawal
Measure
MT-Right
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
Sternotomy
Sternotomy: Longitudinal resection of the sternum
Overall Study
Lost to Follow-up
2
0

Baseline Characteristics

2 patients lost to follow-up

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
MT-Right
n=104 Participants
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
Sternotomy
n=104 Participants
Sternotomy: Longitudinal resection of the sternum
Total
n=208 Participants
Total of all reporting groups
Age, Continuous
36 years
STANDARD_DEVIATION 8 • n=104 Participants
51 years
STANDARD_DEVIATION 13 • n=104 Participants
43.5 years
STANDARD_DEVIATION 10.5 • n=208 Participants
Sex: Female, Male
Female
68 Participants
n=102 Participants • 2 patients lost to follow-up
38 Participants
n=104 Participants • 2 patients lost to follow-up
106 Participants
n=206 Participants • 2 patients lost to follow-up
Sex: Female, Male
Male
34 Participants
n=102 Participants • 2 patients lost to follow-up
66 Participants
n=104 Participants • 2 patients lost to follow-up
100 Participants
n=206 Participants • 2 patients lost to follow-up
Region of Enrollment
Italy
102 participants
n=102 Participants • 2 patients lost to follow-up
104 participants
n=104 Participants • 2 patients lost to follow-up
206 participants
n=206 Participants • 2 patients lost to follow-up

PRIMARY outcome

Timeframe: 12 years

The cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk

Outcome measures

Outcome measures
Measure
MT-Right
n=102 Participants
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
Sternotomy
n=104 Participants
Sternotomy: Longitudinal resection of the sternum
Cardiac Death
3.9 percentage of participants with event
Interval 0.6 to 13.3
3.8 percentage of participants with event
Interval 1.3 to 8.8

PRIMARY outcome

Timeframe: 12 years

The cumulative incidence function (CIF) of recurrent mitral regurgitation (MR) \>\_ 3+, with death as the competing risk

Outcome measures

Outcome measures
Measure
MT-Right
n=102 Participants
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
Sternotomy
n=104 Participants
Sternotomy: Longitudinal resection of the sternum
Severe MR
5.8 percentage of participants with event
Interval 1.8 to 13.4
11.4 percentage of participants with event
Interval 5.9 to 18.8

Adverse Events

MT-Right

Serious events: 11 serious events
Other events: 0 other events
Deaths: 0 deaths

Sternotomy

Serious events: 10 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
MT-Right
n=102 participants at risk
Right minithoracotomy: Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
Sternotomy
n=104 participants at risk
Sternotomy: Longitudinal resection of the sternum
Surgical and medical procedures
Reoperation
10.8%
11/102 • Number of events 11
9.6%
10/104 • Number of events 10

Other adverse events

Adverse event data not reported

Additional Information

Prof. Michele De Bonis

IRCCSSRaffaele

Phone: +390226437102

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place